FRESENIUS KABI USA, LLC
LAKE ZURICH, IL

Fresénius Kabi USA, LLC is a subsidiary of the global healthcare company Fresenius Kabi AG, providing pharmaceutical products and services with a focus on ensuring patient safety. The company emphasizes the responsible use of opioid medications like Morphine Sulfate Injection, recommending them only when alternative treatments are not viable or have proven ineffective. As part of its commitment to transparency, Fresénius Kabi encourages reporting suspected adverse reactions through contact forms available on their official website, freseniuskabiusa.com. The company is incorporated in Florida under model DOS.FloridaCompanyStatus with a significant operational base in Lake Zurich, Illinois. Established on March 4, 2009, Fresénius Kabi USA, LLC operates as a Foreign Corporation for Limited Liability (FORL) and is led by key figures such as John R Ducker among others from affiliated entities like Fresenius Kabi Pharmaceuticals Holdings, Ltd. The company's mailing address is 3 Corporate Drive, Lake Zurich, IL, 60047, with several contact points including (800) 551-7176. Fresénius Kabi USA maintains compliance and corporate updates, as evidenced by its latest annual report filed on April 20, 2024, for the year 2024.